<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Connecting Science Data Using Semantics and Information Extraction</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Evan W. Patton</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Deborah L. McGuinness</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Rensselaer Polytechnic Institute 110 8</institution>
        </aff>
      </contrib-group>
      <abstract>
        <p>We are developing prototypes that explicate our vision of connecting personal medical data to scienti c literature as well as to emerging grey literature (e.g., community forums) to help people nd and understand information relevant to complex medical journeys. We focus on robust combinations of natural language processing along with linked data and knowledge representation to build knowledge graphs that help people make sense of current conditions and enable new manners of scienti c hypothesis generation. We present our work in the context of a breast cancer use case. We discuss the bene ts of biomedical linked data resources and describe some potential assistive technology for navigating rich, diverse medical content.</p>
      </abstract>
      <kwd-group>
        <kwd>knowledge representation</kwd>
        <kwd>explanation</kwd>
        <kwd>clinical notes</kwd>
        <kwd>natural language</kwd>
        <kwd>web forums</kwd>
        <kwd>nanopublications</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>Introduction</title>
      <p>As scienti c knowledge continues to grow in size and diversity, it is increasingly
di cult to discover and manage information relevant to any particular context.
It can be challenging to determine how a statement or report relates to others
and to form and evaluate (often competing) hypotheses, e.g. related to diagnosis
or treatment paths. Complications grow when content is both structured and
unstructured, and when some is from less accredited sources. We aim to expand
the boundaries of Linked Science by focusing on evidence modeling from
natural language processing techniques (NLP) over broad content and by identifying
promising data-driven hypotheses using linked data and nanopublication style
encodings. We present this discussion in the context of a breast cancer
demonstration use case informed by challenges experienced during a co-author's recent
cancer journey. Cancer is a complex disease to manage and treat, often requiring
chemotherapy, surgery, radiation, and drugs to reduce recurrence. We show how
management of this information by the patient is aided by semantic technologies
combined with natural language processing algorithms.</p>
      <p>A breast cancer patient wishes to better understand her diagnosis and
planned treatment. She is interested in expected chemotherapy side
effects, and leveraging experiences of other similar individuals to
proactively nd and evaluate promising coping strategies. She reads through
oncologist-provided documents about her proposed chemotherapy drugs
and uses search engines to nd more about likely adverse e ects that
appear detrimental to her quality of life. She nds con icting opinions
on the e cacy of di erent coping strategies, and needs to determine an
approach to e ectively weigh the possible pros and cons. Managing this
information is mentally taxing and can easily overwhelm a patient.</p>
      <p>Our patient needs to nd and comprehend potentially con icting evidence
about treatment options and side e ects. We propose new software, using a
variety of arti cial intelligence tools built on the interoperability principles
promulgated by linked data and the Semantic Web, to address these challenges.
2</p>
    </sec>
    <sec id="sec-2">
      <title>Evidence Modeling</title>
      <p>The patient uses current technologies to obtain information about her
treatment strategy and to formulate promising side e ect mitigations. This can be
time consuming for anyone, but more so for medically nave patients.
Furthermore, technologies such as web forums or social networking sites are becoming
increasingly common for discourse between patients as they can often include
anecdotal reports, that have not yet been validated through clinical trials, but
may be valuable. They are often presented in layperson terms and sometimes
attract new patients who may be less medically literate. Due to lack of
scienti c rigor, there may be contradictory or unsupported information available, as
shown in the following two answers about a mitigation for the very common,
taxol-related, nail bed problem:</p>
      <p>
        My onc[ology] nurse told me to rub tea tree oil into my cuticles and
nails every night. It is a natural anti-septic and for whatever reason can
sometimes help prevent nail infections and lifting during taxol. 1
I wouldn't use tea tree oil. A friend did on some cracked skin and it got
worse. 2
The rst suggestion is a common preventive approach for nail problems: tea tree
oil prevents nail infections because \it is a natural anti-septic" and appeals to
authority \my onc nurse told me to...". The second suggestion from a di erent
user in the same thread advises against tea tree oil as \a friend [applied tea
tree oil] on some cracked skin and it got worse." Natural Language techniques
may be used to extract coping strategies for particular conditions but without
deeper knowledge, provenance, and tools, the user may not know how to evaluate
and/or integrate potentially contradictory suggestions. We are extending joint
extraction techiques proposed in [
        <xref ref-type="bibr" rid="ref4">4</xref>
        ] with semantic background knowledge to aid
in extracting linked data from medical records.
      </p>
      <sec id="sec-2-1">
        <title>1 https://community.breastcancer.org/forum/69/topic/783573 2 https://community.breastcancer.org/forum/96/topic/745475</title>
      </sec>
    </sec>
    <sec id="sec-3">
      <title>Hypothesis generation using Nanopublications</title>
      <p>
        The Repurposing Drugs using Semantics (ReDrugS) project [
        <xref ref-type="bibr" rid="ref5">5</xref>
        ] has focused on
modeling evidence using small units of publishable information called
Nanopublications [
        <xref ref-type="bibr" rid="ref2">2</xref>
        ]. ReDrugS utilizes linked data sources to build a knowledge base of
nanopublications that is then reasoned about using probabilistic techniques to
identify potential links between proteins, drugs, binding sites, and genes, with
the ultimate aim of discovering possible new o -label uses for FDA-approved
drugs. This project's success has been partially due to the large corpus of linked
data and ontologies generated by the biomedical community over the past few
decades. ReDrugS has ingested content from 17 structured curated data sources,
including content concerning drugs, alternate names, conditions, and pathways.
Once a chemotherapy protocol is extracted from medical notes, ReDrugs can be
used to nd alternative drug names along with related conditions. This
framework, along with the side e ect resource SIDER in process, can be used to
improve the patient's process in nding chemotherapy drug side e ects and some
mitigations by applying its search techniques to authoritative drug resources,
such as looking for anti-nausea prescription drugs. The infrastructure for this
system could be repurposed for other scienti c domains, but only if linked data
sources are abundant in those domains or if quality linked data can be
generated from automated methods, e.g. via natural language processing of web-based
resources.
4
      </p>
    </sec>
    <sec id="sec-4">
      <title>Explanations</title>
      <p>
        We aim to provide extensive explanation mechanisms since explanation is a key
component of transparent systems and user studies have shown that
explanations are required if agents are to be trusted [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ]. We aid explanation generation
through the collection of provenance, modeled using the W3C's PROV
ontology [
        <xref ref-type="bibr" rid="ref3">3</xref>
        ]. PROV-O is a standard for modeling provenance information on the web,
which allows tools to integrate distributed provenance information from di erent
systems. We use this provenance to help construct end user explanations that
include both lineage of content and support (and opposition) for a statement.
      </p>
      <p>
        We identify potential evidence on the use of tea tree oil in
chemotherapyinduced nail bed problems. Not only would a patient want to know evidence,
source, and authoritativeness for both views, she might also want the system
further decompose these arguments and present supporting evidence as to the
antimicrobial nature of tea tree oil in more authoritative sources (e.g. [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ]).
      </p>
      <p>We claim that we can reuse the ReDrugS content to nd prescription drugs
for chemotherapy side e ects. Provenance may be displayed to show that the
recommendation is from a validated authoritative source. While that framework
was originally designed to nd potential new o -label uses for drugs along with
con dence ratings, the explanation component is more critical for our use so that
researchers may inspect evidence sources and the methods used to determine
the system con dence. Without such explanations, people would have di culty
evaluating competing suggestions.</p>
      <p>Our systems3 provide explanation drill down so users can obtain as much
detail as they desire, thus allowing a patient to nd, for example, if authoritative
sources contain prescription drugs for coping with a particular side e ect. Our
NL-based extraction work can be used to identify alternative, possibly
competing, therapies, e.g. an herbal remedy recommended anecdotally with potentially
corroborating authoritative sources.
5</p>
    </sec>
    <sec id="sec-5">
      <title>Discussion and Summary</title>
      <p>Natural Language Processing can expose some of the unstructured content of
medical records as structured content as well as assist in generating linked data
from unstructured sources. The ReDrugS framework provides a
semanticallyintegrated system combining many di erent structured biomedical resources to
generate a broadly reusable knowledge graph. By integrating the natural
language and structured knowledge representation approaches, we can obtain a
much richer annotated knowledge base that includes source and con dence
information. Our prototypes demonstrate some ways that this rich resource may then
be used to help patients and their support networks to discover, integrate, and
evaluate information relevant to complicated medical situations and to help form
transparent and data-driven hypotheses about how to proceed. We believe these
e orts demonstrate some opportunities for future AI-enhanced Linked
Sciencebased assistants that use the wealth of structured content as well as the growing
grey literature collection.</p>
    </sec>
    <sec id="sec-6">
      <title>Acknowledgements</title>
      <p>The authors thank Heng Ji and Alex Borgida for their discussions that helped
shape this work.</p>
      <sec id="sec-6-1">
        <title>3 http://tw.rpi.edu/web/project/MobileHealth</title>
        <p>http://tw.rpi.edu/web/project/ReDrugS</p>
      </sec>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          1.
          <string-name>
            <surname>Glass</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>McGuinness</surname>
            ,
            <given-names>D.L.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Wolverton</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          :
          <article-title>Toward establishing trust in adaptive agents</article-title>
          .
          <source>In: 13th Intl Conference on Intelligent User Interfaces</source>
          . pp.
          <volume>227</volume>
          {
          <issue>236</issue>
          (
          <year>2008</year>
          )
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          2.
          <string-name>
            <surname>Groth</surname>
            ,
            <given-names>P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gibson</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Velterop</surname>
            ,
            <given-names>J.:</given-names>
          </string-name>
          <article-title>The anatomy of a nanopublication</article-title>
          .
          <source>Information Services &amp; Use</source>
          <volume>30</volume>
          ,
          <issue>51</issue>
          {
          <fpage>56</fpage>
          (
          <year>2010</year>
          )
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          3.
          <string-name>
            <surname>Lebo</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Sahoo</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>McGuinness</surname>
            ,
            <given-names>D.L.</given-names>
          </string-name>
          :
          <article-title>PROV-O: The PROV ontology</article-title>
          .
          <source>Tech. rep., W3C</source>
          (
          <year>2013</year>
          )
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          4.
          <string-name>
            <surname>Li</surname>
            ,
            <given-names>Q.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Ji</surname>
          </string-name>
          , H.:
          <article-title>Incremental joint extraction of entity mentions and relations</article-title>
          .
          <source>In: Proc. of the 52nd Annual Meeting of the Association for Computational Linguistics</source>
          (
          <year>2014</year>
          )
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          5.
          <string-name>
            <surname>McCusker</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Solanki</surname>
            ,
            <given-names>K.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Chang</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Dumontier</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Dordick</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>McGuinness</surname>
            ,
            <given-names>D.L.:</given-names>
          </string-name>
          <article-title>A nanopublication framework for systems biology and drug repurposing</article-title>
          .
          <source>In: CSHALS</source>
          <year>2014</year>
          (
          <year>2014</year>
          )
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          6.
          <string-name>
            <surname>Pazyar</surname>
            ,
            <given-names>N.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Yaghoobi</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Bagherani</surname>
            ,
            <given-names>N.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kaerouni</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          :
          <article-title>A review of applications of tea tree oil in dermatology</article-title>
          .
          <source>International Journal of Dermatology</source>
          pp.
          <volume>784</volume>
          {
          <issue>90</issue>
          (
          <year>2013</year>
          )
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>